STAT+: Vertex to buy Alpine Immune Sciences for $4.9 billion
STAT
APRIL 10, 2024
Vertex Pharmaceuticals will buy Alpine Immune Sciences, a maker of protein-based medicines that harness the immune system, for $4.9 billion, the companies announced Wednesday. It is the largest acquisition in Vertex’s history.
Let's personalize your content